Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer
H. Barton Grossman(The University of Texas MD Anderson Cancer Center), E. David Crawford(University of Colorado Denver), Nicholas J. Vogelzang(Comprehensive Cancer Centers of Nevada), Ronald B. Natale(Cedars-Sinai Medical Center), V. O. Speights(White Clinic), Donald L. Trump(Inova Health System), Michael F. Sarosdy(The University of Texas at San Antonio Health Science Center), David P. Wood, Catherine M. Tangen(American Urological Association), Ralph W. deVere White(Marymount University), Derek Raghavan(United States Department of Veterans Affairs)
Cited by 2,636
Related Papers
Frailty in Older Adults: Evidence for a Phenotype
|The Journals of Gerontology Series A|2001|24.4k
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
|New England Journal of Medicine|2017|3.4k
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
|New England Journal of Medicine|2013|3.3k
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
|Journal of Clinical Oncology|2003|3.1k
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
|New England Journal of Medicine|2015|2.8k